These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37609227)

  • 21. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
    Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
    J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular characterization of neurofibromatosis in southern Brazil.
    Rosset C; Vairo F; Cristina Bandeira I; Fonini M; Netto CBO; Ashton-Prolla P
    Expert Rev Mol Diagn; 2018 Jun; 18(6):577-586. PubMed ID: 29685074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers.
    Bewley AF; Akinwe TM; Turner TN; Gutmann DH
    Neurol Genet; 2022 Aug; 8(4):e200003. PubMed ID: 37435433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.
    Kehrer-Sawatzki H; Vogt J; Mußotter T; Kluwe L; Cooper DN; Mautner VF
    Neurogenetics; 2012 Aug; 13(3):229-36. PubMed ID: 22581253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the molecular basis of spinal neurofibromatosis type 1.
    Bettinaglio P; Mangano E; Tritto V; Bordoni R; Paterra R; Borghi A; Volontè M; Battaglia C; Saletti V; Cesaretti C; Natacci F; Melone MAB; Eoli M; Riva P
    Eur J Hum Genet; 2023 Aug; 31(8):931-938. PubMed ID: 37217626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
    Wimmer K
    Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Germinal Neurofibromin Hotspots.
    Lois S; Báez-Flores J; Isidoro-García M; Lacal J; Triviño JC
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.
    Kehrer-Sawatzki H; Cooper DN
    Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).
    Messiaen L; Vogt J; Bengesser K; Fu C; Mikhail F; Serra E; Garcia-Linares C; Cooper DN; Lazaro C; Kehrer-Sawatzki H
    Hum Mutat; 2011 Feb; 32(2):213-9. PubMed ID: 21280148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
    Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Variants and Clinical Characteristics of 16 Patients from Southeast Asia with Genetic Variants in Neurofibromin-1.
    Lin G; Wei H; Lai AHM; Tan ES; Lim JY; Cham B; Ling S; Jamuar SS; Tan EC
    J Pediatr Genet; 2023 Jun; 12(2):135-140. PubMed ID: 37090834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant peripheral nerve sheath tumor on a patient with a maternally inherited novel NF1 gene pathogenic germline variant: Case report.
    Moreno-Salgado R; Rios-Lozano YZ; Tamayo-Palacio AC; Castillo AI; Hidalgo-Martínez MF
    Cancer Genet; 2023 Jun; 274-275():72-74. PubMed ID: 37087941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.
    Pacot L; Pelletier V; Chansavang A; Briand-Suleau A; Burin des Roziers C; Coustier A; Maillard T; Vaucouleur N; Orhant L; Barbance C; Lermine A; Hamzaoui N; Hadjadj D; Laurendeau I; El Khattabi L; Nectoux J; Vidaud M; Parfait B; Dollfus H; Pasmant E; Vidaud D
    Hum Genet; 2023 Jan; 142(1):1-9. PubMed ID: 35941319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?
    Harder A
    Childs Nerv Syst; 2022 Apr; 38(4):705-713. PubMed ID: 34997843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas.
    Trevisson E; Morbidoni V; Forzan M; Daolio C; Fumini V; Parrozzani R; Cassina M; Midena E; Salviati L; Clementi M
    Mol Genet Genomic Med; 2019 May; 7(5):e616. PubMed ID: 30843352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentations of 23 half-siblings from a mosaic neurofibromatosis type 1 sperm donor.
    Ejerskov C; Farholt S; Skovby F; Vestergaard EM; Haagerup A
    Clin Genet; 2016 Mar; 89(3):346-50. PubMed ID: 25872886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.
    Wang W; Wei CJ; Cui XW; Li YH; Gu YH; Gu B; Li QF; Wang ZC
    Front Neurol; 2021; 12():704639. PubMed ID: 34566848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One
    Pacot L; Burin des Roziers C; Laurendeau I; Briand-Suleau A; Coustier A; Mayard T; Tlemsani C; Faivre L; Thomas Q; Rodriguez D; Blesson S; Dollfus H; Muller YG; Parfait B; Vidaud M; Gilbert-Dussardier B; Yardin C; Dauriat B; Derancourt C; Vidaud D; Pasmant E
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31443423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India.
    Spolia A; Angural A; Sharma V; Shipra ; Razdan S; Dhar MK; Mahajan A; Verma V; Pandita KK; Sharma S; Rai E
    Sci Rep; 2023 May; 13(1):7852. PubMed ID: 37188759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.